Male Infertility
Male infertility can involve sperm production, function or transport. Learn about possible causes, semen analysis, diagnosis and treatment pathways.
Male infertility describes a reduced ability to contribute to conception. Often there is no obvious physical symptom: difficulty achieving pregnancy may be the first reason to investigate. A semen analysis is an essential starting point when sperm from a male partner is involved, but a single result does not explain every fertility problem. Assessment usually considers the reproductive health of both partners where relevant. Through ZagrebMed, you can request a specialist evaluation in Zagreb and share prior findings before an appointment.
What the condition means
Male infertility is not one single diagnosis. It can involve a low number of sperm, reduced movement, abnormal sperm structure, impaired production or difficulty delivering sperm into the ejaculate. Some men have normal semen parameters despite a fertility problem, and semen results also vary over time. Fertility is therefore assessed in the context of a person's history and their partner's findings, rather than by reading one laboratory number in isolation.
Possible causes and associated signs
Potential contributing factors include varicocele, previous undescended testis, genetic conditions, hormonal disorders, obstruction of the reproductive tract, infections, earlier surgery, cancer treatment and certain medications or exposures. Smoking, anabolic steroids and excessive heat may affect sperm production. Symptoms such as testicular pain, swelling, reduced sexual desire or difficulties with ejaculation merit discussion but may be absent. The cause often remains uncertain even after investigation.
How fertility specialists investigate it
An initial urological consultation can review medical, surgical and reproductive history, physical findings and the timing of attempts to conceive. Semen analysis measures concentration, movement, volume and morphology; an abnormal result is commonly repeated because measurements fluctuate and collection conditions matter. Selected blood tests, including testosterone and follicle-stimulating hormone, or genetic studies may be appropriate based on the pattern of abnormalities. Ultrasound and advanced sperm tests are not automatically required for every patient.
What the next step may involve
Management depends on the specific finding and the other partner's reproductive situation. Addressing a reversible factor or a clinically significant condition may be considered when appropriate. With severe sperm abnormalities, IVF with ICSI may be discussed, while surgical sperm retrieval can be relevant in selected cases. Neither assisted reproduction nor surgery guarantees pregnancy. Testing for sperm DNA fragmentation is not a routine first-line test; its usefulness depends on the particular clinical history.
When to seek medical attention
Infertility evaluation is commonly offered after 12 months of regular unprotected intercourse when the female partner is younger than 35, after six months at 35 or above, or earlier when a known fertility-related condition exists. Men with a painful or swollen testicle, a new testicular lump or acute severe scrotal pain need timely medical assessment; sudden severe pain is urgent. Do not wait for a fertility appointment to evaluate an acute testicular emergency.
What individual findings change
A semen analysis should be interpreted as a combination of findings, not a pass-or-fail fertility score. A low concentration with normal movement may suggest a different next step from a very low total motile sperm count. Persistently abnormal findings are more informative than a single unusual specimen. When the reproductive history suggests a hormonal problem, carefully selected hormone tests help clarify whether sperm production is being affected. When a physical examination suggests a varicocele, the specialist can discuss whether that finding is clinically relevant. If there is a history of chemotherapy or testicular surgery, records may change the investigation. Advanced tests are useful only if the result is expected to affect treatment; an expanded panel is not automatically more accurate.
Planning realistic next steps
A fertility consultation should clarify whether both partners have completed basic evaluation and which issue is likely to influence the timing of care most. Age and ovulatory or tubal factors on the other side of the reproductive pathway can affect whether the couple chooses to continue trying, address a specific cause or consider assisted reproduction. If a semen result is abnormal, ask whether repeat collection is necessary, what each parameter means and which findings change management. It is also reasonable to discuss exposures, medications, sexual health and potential genetic implications. Treatment is a shared decision that balances clinical evidence, preferences, burden and the possibility that a cause remains unknown.
The fertility pathway should also account for circumstances that are sometimes overlooked during an initial appointment. Sexual-function difficulties, inability to provide a sample, past use of testosterone for athletic or medical purposes, and reproductive surgery may require a different conversation from an isolated borderline semen result. The absence of obvious symptoms is not proof that sperm production is normal. A history of fathering a child does not exclude a new reproductive problem, because health, age and exposures may change. Likewise, a reassuring semen result cannot rule out other causes of infertility in the couple. Asking which findings are actionable can prevent repeated examinations that do not affect care. A transparent plan should specify whether a result needs confirmation, which factors can be treated and when the impact of any intervention can reasonably be reassessed.
Preparing for a ZagrebMed inquiry
Before contacting ZagrebMed, prepare any semen analyses, hormone results, operative records, information about past infections or cancer treatment, current medicines and relevant fertility results from the other partner. Note how long conception has been attempted and whether symptoms or sexual-function concerns exist. A specialist can decide which findings need confirmation, which tests add value and whether a medical, surgical or assisted-reproduction pathway is appropriate.
Related fertility concerns
Male-factor infertility includes different patterns, and patients often benefit from understanding the distinction between azoospermia, when no sperm are detected in the ejaculate, and oligozoospermia, when the concentration is reduced. Neither label alone identifies the cause or determines the treatment. A clinician interprets both within the overall fertility assessment.
Medical references
Medical sources: AUA/ASRM Guideline on Diagnosis and Treatment of Infertility in Men (amended 2024); WHO Guideline for the Prevention, Diagnosis and Treatment of Infertility (2025); ASRM Fertility Evaluation of Infertile Women (2026).